All In Biotech

Free tool

Medicare drug spending

CMS's Spending by Drug data: what Medicare paid for each drug before manufacturer rebates. Part D covers drugs dispensed by pharmacies; Part B covers drugs given in a doctor's office or hospital outpatient department. Commercial and list prices are not public data and are not shown.

Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations

Part D, 2024

$288.7B

Gross drug spending in the dataset

Part B, 2024

$60.8B

Gross drug spending in the dataset

Drugs listed

10

Part D and Part B

Total spending by year

  • Part D
  • Part B
View as table
YearPart DPart B
2020$194,092,038,339$37,778,829,680
2021$213,513,349,361$40,135,340,775
2022$239,779,215,689$44,241,259,745
2023$275,808,918,753$50,775,853,083
2024$288,667,842,058$60,838,164,403
Reset

Top 10 by total spending

2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.

DrugPartSpendingChangeBeneficiariesPer beneficiaryPer unit
Epinephrine

Epinephrine

D$119M-11%458,644$260$99.63
Auvi-Q

Epinephrine

D$713K-1%876$814$300.57
Neffy

Epinephrine

D$210Kn/a255$825$340.89
Epipen 2-Pak

Epinephrine

D$167K-81%243$689$291.17
Adrenalin

Epinephrine

D$61K+20%2,713$22$13.74
Epinephrine

Epinephrine HCL/PF · J0173

B$28Kn/a1,177$24$1.87
Adrenalin*

Epinephrine* · J0171

B$11K+10%2,258$5$1.58
Xylocaine With Epinephrine

Lidocaine HCl/Epinephrine

D$1K+168%72$15$0.37
Xylocaine-MPF With Epinephrine

Lidocaine HCl/Epinephrine/PF

D$438n/a11$40$0.89
Lidocaine HCl-Epinephrine

Lidocaine HCl/Epinephrine

D$188-79%35$5$0.26

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.